Literature DB >> 28242111

Cataracts.

Yu-Chi Liu1, Mark Wilkins2, Terry Kim3, Boris Malyugin4, Jodhbir S Mehta5.   

Abstract

An estimated 95 million people worldwide are affected by cataract. Cataract still remains the leading cause of blindness in middle-income and low-income countries. With the advancement of surgical technology and techniques, cataract surgery has evolved to small-incisional surgery with rapid visual recovery, good visual outcomes, and minimal complications in most patients. With the development of advanced technology in intraocular lenses, the combined treatment of cataract and astigmatism or presbyopia, or both, is possible. Paediatric cataracts have a different pathogenesis, surgical concerns, and postoperative clinical course from those of age-related cataracts, and the visual outcome is multifactorial and dependent on postoperative visual rehabilitation. New developments in cataract surgery will continue to improve the visual, anatomical, and patient-reported outcomes. Future work should focus on promoting the accessibility and quality of cataract surgery in developing countries.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28242111     DOI: 10.1016/S0140-6736(17)30544-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  146 in total

1.  Cataract risk in US radiologic technologists assisting with fluoroscopically guided interventional procedures: a retrospective cohort study.

Authors:  Raquel Velazquez-Kronen; David Borrego; Ethel S Gilbert; Donald L Miller; Kirsten B Moysich; Jo L Freudenheim; Jean Wactawski-Wende; Elizabeth K Cahoon; Mark P Little; Amy E Millen; Stephen Balter; Bruce H Alexander; Steven L Simon; Martha S Linet; Cari M Kitahara
Journal:  Occup Environ Med       Date:  2019-03-19       Impact factor: 4.402

2.  Reduced Glutathione Level Promotes Epithelial-Mesenchymal Transition in Lens Epithelial Cells via a Wnt/β-Catenin-Mediated Pathway: Relevance for Cataract Therapy.

Authors:  Zongbo Wei; Jane Caty; Jeremy Whitson; Amy D Zhang; Ramkumar Srinivasagan; Terrance J Kavanagh; Hong Yan; Xingjun Fan
Journal:  Am J Pathol       Date:  2017-08-19       Impact factor: 4.307

3.  Celastrol inhibits migration, proliferation and transforming growth factor-β2-induced epithelial-mesenchymal transition in lens epithelial cells.

Authors:  Li-Ping Wang; Bao-Xin Chen; Yan Sun; Jie-Ping Chen; Shan Huang; Yi-Zhi Liu
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

4.  Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.

Authors:  Mahbubul H Shihan; Samuel G Novo; Melinda K Duncan
Journal:  Curr Med Res Opin       Date:  2019-08-28       Impact factor: 2.580

5.  Kinetic Stability of Long-Lived Human Lens γ-Crystallins and Their Isolated Double Greek Key Domains.

Authors:  Ishara A Mills-Henry; Shannon L Thol; Melissa S Kosinski-Collins; Eugene Serebryany; Jonathan A King
Journal:  Biophys J       Date:  2019-06-14       Impact factor: 4.033

6.  Long-Term Evaluation of Capsulotomy Shape and Posterior Capsule Opacification after Low-Energy Bimanual Femtosecond Laser-Assisted Cataract Surgery.

Authors:  Tommaso Verdina; Chiara Peppoloni; Lucrezia Barbieri; Maria Rosaria Carbotti; Bruno Battaglia; Rodolfo Mastropasqua; Gian Maria Cavallini
Journal:  J Ophthalmol       Date:  2020-09-23       Impact factor: 1.909

7.  Fibronectin has multifunctional roles in posterior capsular opacification (PCO).

Authors:  Mahbubul H Shihan; Mallika Kanwar; Yan Wang; Erin E Jackson; Adam P Faranda; Melinda K Duncan
Journal:  Matrix Biol       Date:  2020-03-12       Impact factor: 11.583

8.  The myofibroblast, biological activities and roles in eye repair and fibrosis. A focus on healing mechanisms in avascular cornea.

Authors:  Maxime Rocher; Pierre-Yves Robert; Alexis Desmoulière
Journal:  Eye (Lond)       Date:  2019-11-25       Impact factor: 3.775

Review 9.  Lens regeneration: scientific discoveries and clinical possibilities.

Authors:  Yuzhou Gu; Ke Yao; Qiuli Fu
Journal:  Mol Biol Rep       Date:  2021-06-18       Impact factor: 2.316

10.  Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial.

Authors:  Chee Wai Wong; Edmund Wong; Josbert M Metselaar; Gert Storm; Tina T Wong
Journal:  Drug Deliv Transl Res       Date:  2021-02-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.